Eric Richman - Mar 1, 2022 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
Director
Signature
/s/ Dietrich A. Stephan, as attorney-in-fact for Eric I. Richman
Stock symbol
NBSE
Transactions as of
Mar 1, 2022
Transactions value $
$6,352
Form type
4
Date filed
3/7/2022, 06:13 PM
Previous filing
Sep 17, 2021
Next filing
May 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBSE Common stock Purchase $2.5K +1.58K +3.85% $1.58 42.7K Mar 1, 2022 Direct F1, F3
transaction NBSE Common stock Purchase $2.24K +1.3K +3.05% $1.72 44K Mar 3, 2022 Direct F1, F4
transaction NBSE Common stock Purchase $1.62K +1K +2.27% $1.62 45K Mar 4, 2022 Direct F1
holding NBSE Common stock 27.7K Mar 1, 2022 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The power of attorney under which this form was signed is on file with the Commission.
F2 Shares are held in a trust for the benefit of the Reporting Person with the Reporting Person and the Reporting Person's spouse serving as co-trustees.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.57 to $1.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4 These shares were purchased in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased in at each separate transaction.